Factor V Leiden Mutation in the Argentinian Population

• References

• 1 Svensson PJ, Dahlbäck B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1993; 330: 517-22.
• 2 Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
• 3 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346: 1133-4.
• 4 Fujimura H, Kambayashi J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost 1996; 74: 1381-2.
• 5 Dahlbäck B. Resistance to activated protein C caused by the factor V R⁵⁰⁶Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997; 78: 483-8.
• 6 Hepner M, Roldán A, Pieroni G, Frontroth J, Serviddio RM, Feliú Torres A, Sciuccati G, Bonduel M. Frequency of factor V Arg⁵⁰⁶ to Gln mutation (FV Leiden) and activated protein C resistance in blood donors in Argentina. A preliminary study. Thromb Haemost 1997; (Suppl. 01) 919a (abstract)
• 7 Kawasaki ES. Sample preparation from blood, cells and other fluids. In PCR protocols Innis MA, Gelfand DH, Sninsky JJ, White TJ. eds San Diego: Academic Press; 1990: 146.
• 8 Schröder W, Koesling M, Wulff K, Wehnert M, Herrmann FH. Large-scale screening for factor V Leiden mutation in a north-eastern German population. Haemostasis 1996; 26: 233-6.